Literature DB >> 17882017

Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.

Marco Vercellino1, Aristide Merola, Chiara Piacentino, Barbara Votta, Elisabetta Capello, Giovanni Luigi Mancardi, Roberto Mutani, Maria Teresa Giordana, Paola Cavalla.   

Abstract

Cortical involvement in multiple sclerosis (MS) is emerging as an important determinant of disease progression. The mechanisms responsible for MS cortical pathology are not fully characterized. The objective of this study was to assess the role of excitotoxicity in MS cortex, evaluating excitatory amino acid transporter (EAAT) expression and its relationship with demyelination, inflammation, gliosis, and neuronal and synaptic pathology. EAATs are essential in maintaining low extracellular glutamate concentrations and preventing excitotoxicity. Ten MS brains (3 relapsing-remitting MS cases and 7 secondary progressive MS cases) were evaluated by immunohistochemistry for myelin basic protein, CD68, HLA-DR, EAAT1, EAAT2, glial fibrillary acidic protein, phosphorylated c-Jun N-terminal kinase (pJNK), synaptophysin, and neurofilaments. Cortical lesions were frequently observed in MS brains in variable numbers and extensions. In cortical lesions, activated microglia infiltration correlated with focal loss of EAAT1, EAAT2, and synaptophysin immunostaining, and with neuronal immunostaining for pJNK, a protein involved in response to excitotoxic injury. No reduction of EAATs or synaptophysin immunostaining was observed in demyelinated cortex in the absence of activated microglia. Alterations of the mechanisms of glutamate reuptake are found in cortical MS lesions in the presence of activated microglia and are associated with signs of neuronal and synaptic damage suggestive of excitotoxicity. Excitotoxicity may be involved in the pathogenesis of demyelination and of neuronal and synaptic damage in MS cortex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17882017     DOI: 10.1097/nen.0b013e31812571b0

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  66 in total

Review 1.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

2.  Glutamate Transporters: Expression and Function in Oligodendrocytes.

Authors:  Edna Suárez-Pozos; Elizabeth J Thomason; Babette Fuss
Journal:  Neurochem Res       Date:  2019-01-09       Impact factor: 3.996

3.  Decreased number and increased volume with mitochondrial enlargement of cerebellar synaptic terminals in a mouse model of chronic demyelination.

Authors:  Huy Bang Nguyen; Yang Sui; Truc Quynh Thai; Kazuhiro Ikenaka; Toshiyuki Oda; Nobuhiko Ohno
Journal:  Med Mol Morphol       Date:  2018-05-23       Impact factor: 2.309

4.  Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis.

Authors:  Kristin P O'Grady; Adrienne N Dula; Bailey D Lyttle; Lindsey M Thompson; Benjamin N Conrad; Bailey A Box; Lydia J McKeithan; Siddharama Pawate; Francesca Bagnato; Bennett A Landman; Paul Newhouse; Seth A Smith
Journal:  Mult Scler       Date:  2018-09-19       Impact factor: 6.312

Review 5.  The role of glutamate and its receptors in multiple sclerosis.

Authors:  Ivana R Stojanovic; Milos Kostic; Srdjan Ljubisavljevic
Journal:  J Neural Transm (Vienna)       Date:  2014-03-15       Impact factor: 3.575

6.  Reduced expression of plasma membrane calcium ATPase 2 and collapsin response mediator protein 1 promotes death of spinal cord neurons.

Authors:  M P Kurnellas; H Li; M R Jain; S N Giraud; A B Nicot; A Ratnayake; R F Heary; S Elkabes
Journal:  Cell Death Differ       Date:  2010-05-21       Impact factor: 15.828

Review 7.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

Review 8.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

9.  Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Authors:  Athena M Soulika; Eunyoung Lee; Erica McCauley; Laird Miers; Peter Bannerman; David Pleasure
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

10.  Neuromuscular electrical stimulation and dietary interventions to reduce oxidative stress in a secondary progressive multiple sclerosis patient leads to marked gains in function: a case report.

Authors:  David Reese; Ezzatolah T Shivapour; Terry L Wahls; Shauna D Dudley-Javoroski; Richard Shields
Journal:  Cases J       Date:  2009-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.